• Reports

      Reports

      Stay ahead and make informed decisions with Delvens insightful analysis on key business and technological trends.

      How We Can help you
      • Healthcare
      • Automotive
      • Chemicals & Materials
      • Aerospace & Defense
      • Semiconductors & Electronics
      • Food & Beverages
      • Pharmaceutical
      • IT & Telecom
      • Energy
      • Consumer Goods & Services
  • Best Practice Guide

      Best Practice Guides

      The Delvens Best Practice Team offers practical tactics, procedures, and resources to help you address the major growth-related dos and don'ts.

      How We Can help you
      • Healthcare
      • Automotive
      • Chemicals & Materials
      • Aerospace & Defense
      • Semiconductors & Electronics
      • Food & Beverages
      • Pharmaceutical
      • IT & Telecom
      • Energy
      • Consumer Goods & Services
  • Expertise

      Expertise

      Delvens' decades of experience helps you to strategize, plan, optimize and win.

      See What we can do
      • Syndicated Research
      • Custom Research
      • Consulting
      • Implementation Support
      • Audio-Video Infographic Workshops
      • Subscription Model
      • Bundle Reports Model
      • Best Practice Guides
  • Innovation

      Innovation

      Gain thought-provoking insights on some of the biggest trends in the world to guide you in the phase of innovation.

      Let's Innovate

      Latest Chronicles

      Pharma Businesses

      Pharma businesses that are rewired will win in the digital era

      13th July 2023

      Featured Chronicle

      ESG

      Why ESG is more important than ever!

      4th November 2022
  • Innovation
  • Explore

      Explore

      From accelerating growth and providing strategic vision to the world's biggest brands, to lunch-break sneaker shopping on Melrose, and thirsty Thursdays at the local pubs. We have a Hustling atmosphere because growing together should be fun, or why do it?

      Let's Explore Something

      About

      • Who We Are
      • Why Choose Us
      • Research Methodology
      • Careers
      • Contact

      Help

      • Customer FAQs
      • How To Order
      • Delivery Method
      • Return Policy
      • Privacy Policy
      • Terms of Use
  • Newscast

      Blogs

      The Pros and Cons of Cloud Computing

      The Pros and Cons of Cloud Computing

      13th July 2023
      Let's Read

      Press Room

      Healthcare AI Innovation

      Healthcare AI innovation: a new era of patientcare

      13th July 2023
      Let's Understand

      Article

      Electric Vehicle Thermal Management System (EVTMS) Market

      19th May 2023
      Let's Study
  • Newscast
      • Blog
      • Article
      • Pressroom
Healthcare Icon

Bladder Cancer Market – Trends Forecast Till 2030

Bladder Cancer Market, By Type (Transitional Cell Carcinoma, Invasive Bladder Cancer, Superficial Bladder Cancer, Adenocarcinomax, and Other Rare Types), By Treatment (Chemotherapy, Radiation Therapy, Immunotherapy, Radical Cystectomy, and Others), By Diagnosis (Urine Lab Tests, Cystoscopy, Biopsy, Imaging Test, and Others), By End User (Hospital, Clinic, Cancer Care Centers, and Others) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).

  • Published Date : August 2023
  • Base Year Estimate : 2022
  • Report ID : D-HC-BCM-1514
  • Format :
  • Number of Pages : 590
  • Domain : Healthcare
  1. Healthcare
  2. Bladder Cancer Market – Trends Forecast Till 2030
Buy Now Get Free Sample Now
REPORT SYNOPSIS
Market Snapshot Market Overview Delvens Industry Expert's Standpoint Market Portfolio Key Findings Regional Analysis Competitive Landscape Recent Developments Reasons to Acquire Report Scope
Table Of Content Frequently Asked Questions

Market Snapshot

Market Overview

The global Bladder Cancer market size was estimated at USD 5.25 billion in 2023 and is projected to reach USD 7.52 billion in 2030 at a CAGR of 4.60% during the forecast period 2023-2030.

Bladder cancer occurs when the cells that make up the bladder begin to multiply uncontrollably. More cancer cells can form a tumor and spread to other parts of the body over time. The bladder wall consists of several layers. Each layer consists of several types of cells. The urothelium, or transitional epithelium, lining the inside of the bladder is where most bladder malignancies begin. Cancer progresses to a higher stage, progresses, and is more difficult to treat when it spreads to or through other layers of the bladder wall. Over time, cancer can spread outside the bladder and into adjacent structures. It can spread to nearby lymph nodes or other organs.

The bladder cancer therapeutics and diagnostics market may witness rapid growth due to the increasing awareness about bladder diseases and available therapies, along with growing healthcare expenditure and the growing burden of bladder cancer. For instance, in March 2022, the 'Don't Go Red' theme for Bladder Cancer Awareness has been declared by World Bladder Cancer Patient Coalition to raise awareness of warning signs and symptoms, as early detection is critical for enhancing long-term survival and quality of life. Such initiatives are expected to boost market growth over the forecast period.

The spread of the COVID-19 pandemic had a significant impact on the bladder cancer market. During the first wave, the surgical volume was not compromised. Treatment-related alterations were kept to a minimum and adhered to the revised guidelines. During the peak of the COVID-19 pandemic in 2020, more than a quarter of patients with bladder cancer experienced care delays in the United States. As a result of the pandemic, the market for bladder cancer therapeutics and diagnostics had been significantly impacted.

Delvens Industry Expert's Standpoint

The pandemic had a considerable impact on businesses globally, with nations like India and China bearing the brunt of the virus's outbreak. Factors such as increasing incidence of bladder cancer, growing awareness about cancer and its available treatments, rising healthcare costs, increasing smoking and tobacco consumption are expected to accelerate the maturation of the global bladder cancer market. Additionally, the prevalence of bladder cancer across the world supports the expansion of the market during the forest season. For example, the Global Cancer Observatory Statistics 2020 reports that bladder cancer and prostate cancer are among the 10 most common cancers in the world. The same source also reports that the number of new cases of bladder cancer was estimated to be 573,278 in 2020 and the number of prostate cancer cases was 1,414,259 in both sexes in 2020. Such a high incidence of cancer worldwide will drive the market over time. Additionally, increasing focus of key players on various growth strategies such as R&D and product approval is expected to further boost the market. These factors have led to the expansion of the market and increased demand for Bladder Cancer solutions.

Market Portfolio

Key Findings

  • The type segment is further fragmented into Transitional Cell Carcinoma, Invasive Bladder Cancer, Superficial Bladder Cancer, Adenocarcinomax, and Other Rare Types. The Transitional Cell Carcinoma, Invasive Bladder Cancer, Superficial Bladder Cancer, Adenocarcinomax, and Other Rare Types segment is expected to account for a larger market size during the forecast period. Healthcare infrastructures in wealthy and developing countries have improved as a result. The superficial bladder cancer segment will witness rapid growth in the global bladder cancer drugs market during the forecast period. The expansion of this segment is due to the growing awareness of superficial bladder diseases, improvement of healthcare infrastructures in developed and developing countries, and technological advancements.
  • The Treatment segment is further bifurcated into Chemotherapy, Radiation Therapy, Immunotherapy, Radical Cystectomy, and Others. The Chemotherapy is the largest market during the forecast period. Several chemotherapy drugs of 2021 are to blame for this. On the other hand, the bladder cancer treatment market is expected to show a good growth rate in the immunotherapy category. Increasing incidence of target diseases, growing preference for immunotherapy over traditional treatments, and growing demand for monoclonal antibodies and biosimilars are the major drivers for the growth of the immunotherapy segment.
  • The diagnosis segment is further bifurcated into Urine Lab Tests, Cystoscopy, Biopsy, Imaging Test, and Others. Cystoscopy to account for a larger market size during the forecast period. During the procedure known as cystoscopy, a telescope is used to look inside the bladder and urethra. For a direct visual examination of the urothelium, a cystoscope is a special endoscope that is inserted into the bladder through the urethra. Cystoscopy is economical. Increasing use of cystoscopy, increasing incidence of bladder cancer and product debuts by major market players are contributing to the growth of this market segment.
     
  • The market is also divided into various regions such as North America, Europe, Asia-Pacific, South America, and Middle East and Africa. North America is estimated to account for the largest market share during the forecast period. Due to the region's expanding R&D activities and well-established healthcare infrastructure.

Regional Analysis

North America to Dominate the Market

  • North America is estimated to account for the largest market share during the forecast period. Due to the region's expanding R&D activities and well-established healthcare infrastructure.
     
  • Moreover, the existence of numerous biologics and biopharmaceutical firms is another factor that has contributed to the bladder cancer therapies and diagnostics market's size and stellar growth.